Carrier-protein conjugated synthetic peptide encompassing a sequence within the N-terminus region of Hepatitis C virus E2 protein (HCV 2a (strain JFH-1)). The exact sequence is proprietary.
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
1XPBS ( pH 7), 40 % Glycerol, 0.01 % Thimerosal
Konservierungsmittel
Thimerosal (Merthiolate)
Vorsichtsmaßnahmen
This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
Target
HCV E2
(Hepatitis C Virus Envelope Protein E2 (HCV E2))